Rajeev Dadoo - 25 Jun 2025 Form 4 Insider Report for ARS Pharmaceuticals, Inc. (SPRY)

Role: Director
Signature: /s/ Sasha Keough, attorney-in-fact for Rajeev Dadoo
Issuer symbol: SPRY
Transactions as of: 25 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 27 Jun 2025, 16:43:08 UTC
Previous filing: 24 Jun 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Dadoo Rajeev	Director	985 OLD EAGLE SCHOOL ROAD, SUITE 511, WAYNE	/s/ Sasha Keough, attorney-in-fact for Rajeev Dadoo	27 Jun 2025	0001951685

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SPRY	Stock Option (right to buy)	Award	$0	+30,000		$0.000000	30,000	25 Jun 2025	Common Stock	30,000	$17.26	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option will vest in full on the earlier of June 25, 2026 or the date of the Issuer's 2026 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors.